Iq Corp.
Country not established
- Devices
- 1
What Iq Corp. makes
Iq Corp. manufactures flow cytometry reagents, including triple-color kits for immune cell phenotyping such as CD45-FITC/CD4-PE/CD3-CYQ and CD45-FITC/CD8-PE/CDQ. These products are designed for laboratory use in hematology and immunology diagnostics, enabling multi-parameter analysis of blood and bone marrow samples.
The company’s flow cytometry reagents are classified as Class II medical devices under FDA regulations and are supported by 510(k) clearances. The portfolio is listed in the FDA’s 510(k) database, reflecting regulatory compliance for in vitro diagnostic use in the United States.
Catalogue
- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Iq Corp. have in the registry?
The registry currently lists 1 device for Iq Corp.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Iq Corp.'s devices?
Among its 1 most recently registered device, Iq Corp. has devices listed in FDA 510(k) (1 device).
What risk classes do Iq Corp.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Iq Corp.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Iq Corp. in the registry?
The most recently registered devices listed for Iq Corp. include IQ PRODUCTS TRIPLE-COLOR FLOW CYTOMETRY REAGENTS, IQ PRODUCTS CD45-FITC/CD4-PE/CD3-CYQ, IQ PRODUCTS CD45-FITC/CD8-PE/CDQ.